BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17545520)

  • 1. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
    Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
    Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
    Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
    Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
    Ming F; Sun Q
    Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
    Ramaswamy B; Majumder S; Roy S; Ghoshal K; Kutay H; Datta J; Younes M; Shapiro CL; Motiwala T; Jacob ST
    Mol Endocrinol; 2009 Feb; 23(2):176-87. PubMed ID: 19095770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
    Liu TH; Raval A; Chen SS; Matkovic JJ; Byrd JC; Plass C
    Cancer Res; 2006 Jan; 66(2):653-8. PubMed ID: 16423993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.
    Jacob ST; Motiwala T
    Cancer Gene Ther; 2005 Aug; 12(8):665-72. PubMed ID: 15803146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
    Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
    Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Wakim J; Arman E; Becker-Herman S; Kramer MP; Bakos E; Shachar I; Elson A
    Oncogene; 2017 Jun; 36(26):3686-3694. PubMed ID: 28166196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
    Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
    J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
    Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
    Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
    Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.
    Motiwala T; Zanesi N; Datta J; Roy S; Kutay H; Checovich AM; Kaou M; Zhong Y; Johnson AJ; Lucas DM; Heerema NA; Hagan J; Mo X; Jarjoura D; Byrd JC; Croce CM; Jacob ST
    Blood; 2011 Dec; 118(23):6132-40. PubMed ID: 22001392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
    Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
    Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.